Epicore Bionetworks Inc. V.EBN

Feels like the market is seeing what I saw

[ChaseYourDream]

...but not bothering to post.

The Q3 FS was as I predicted (all is well), and we got back to fair value of .60+

The Q2 dip to .37-.40 was way oversold, but a great opportunity for those paying attention. Now I catch myself feeling .71 is too high (for the ST). The volume is too thin.

But even if the SP settles to .60-.68 the fundamentals say HOLD. The next FS will confirm this is a blue chip pennystock and another strong advance will follow.

[linpaws]

Not sure how you came up with 0.60 as fair value. If you do a DCF valuation, this stock should be above $1.00. I suspect it will test previous highs and should settle around around $1.00 in the next few months. I do not think that 0.71 is high. As I said before, even without pricing in any growth, this stock should be $0.68. Just my two cents!

[ChaseYourDream]

linpaws - (6/4/2016 10:42:47 PM) SAID Not sure how you came up with 0.60 as fair value. If you do a DCF valuation, this stock should be above $1.00. I suspect it will test previous highs and should settle around around $1.00 in the next few months. I do not think that 0.71 is high. As I said before, even without pricing in any growth, this stock should be $0.68. Just my two cents! Welcome

[linpaws]

Good post! The calculation I used was the earnings based DCF valuation. At 0.05 EPS, if you assume absolutely no growth and discount rate of 7%, you get a value of 0.71 (0.05/0.07). Let's assume a 5% growth over a 10 year period with terminal growth rate of 3% and discount rate as 7%, you will come up with a value of $1.19 ((0.05 x 1.62 x 1.03)/0.07). This is still ridiculously cheap. This can

[ChaseYourDream]

Well, there are at least two of us... and 6-8 readers ;-) Thanks